These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16652281)

  • 1. Long-term protection against carriage of hepatitis B virus after infant vaccination.
    van der Sande MA; Waight P; Mendy M; Rayco-Solon P; Hutt P; Fulford T; Doherty C; McConkey SJ; Jeffries D; Hall AJ; Whittle HC
    J Infect Dis; 2006 Jun; 193(11):1528-35. PubMed ID: 16652281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages.
    Whittle HC; Maine N; Pilkington J; Mendy M; Fortuin M; Bunn J; Allison L; Howard C; Hall A
    Lancet; 1995 Apr; 345(8957):1089-92. PubMed ID: 7715343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term protection against HBV chronic carriage of Gambian adolescents vaccinated in infancy and immune response in HBV booster trial in adolescence.
    van der Sande MA; Waight PA; Mendy M; Zaman S; Kaye S; Sam O; Kahn A; Jeffries D; Akum AA; Hall AJ; Bah E; McConkey SJ; Hainaut P; Whittle HC
    PLoS One; 2007 Aug; 2(8):e753. PubMed ID: 17710152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of hepatitis B vaccine in the Gambian expanded programme on immunisation.
    Fortuin M; Chotard J; Jack AD; Maine NP; Mendy M; Hall AJ; Inskip HM; George MO; Whittle HC
    Lancet; 1993 May; 341(8853):1129-31. PubMed ID: 8097813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and effectiveness of infant vaccination against chronic hepatitis B in the Gambia Hepatitis Intervention Study (1986-90) and in the nationwide immunisation program.
    Peto TJ; Mendy ME; Lowe Y; Webb EL; Whittle HC; Hall AJ
    BMC Infect Dis; 2014 Jan; 14():7. PubMed ID: 24397793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B vaccination in infancy in The Gambia: protection against carriage at 9 years of age.
    Viviani S; Jack A; Hall AJ; Maine N; Mendy M; Montesano R; Whittle HC
    Vaccine; 1999 Aug; 17(23-24):2946-50. PubMed ID: 10462228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination against hepatitis B and protection against chronic viral carriage in The Gambia.
    Whittle HC; Inskip H; Hall AJ; Mendy M; Downes R; Hoare S
    Lancet; 1991 Mar; 337(8744):747-50. PubMed ID: 1672389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Observational study of vaccine efficacy 14 years after trial of hepatitis B vaccination in Gambian children.
    Whittle H; Jaffar S; Wansbrough M; Mendy M; Dumpis U; Collinson A; Hall A
    BMJ; 2002 Sep; 325(7364):569. PubMed ID: 12228132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The first five years of universal hepatitis B vaccination in South Africa: evidence for elimination of HBsAg carriage in under 5-year-olds.
    Tsebe KV; Burnett RJ; Hlungwani NP; Sibara MM; Venter PA; Mphahlele MJ
    Vaccine; 2001 Jul; 19(28-29):3919-26. PubMed ID: 11427266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Observational study of vaccine efficacy 24 years after the start of hepatitis B vaccination in two Gambian villages: no need for a booster dose.
    Mendy M; Peterson I; Hossin S; Peto T; Jobarteh ML; Jeng-Barry A; Sidibeh M; Jatta A; Moore SE; Hall AJ; Whittle H
    PLoS One; 2013; 8(3):e58029. PubMed ID: 23533578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence of immune memory and immunity to hepatitis B virus in adults after neonatal hepatitis B vaccination.
    Zhu CL; Liu P; Chen T; Ni Z; Lu LL; Huang F; Lu J; Sun Z; Qu C
    Vaccine; 2011 Oct; 29(44):7835-41. PubMed ID: 21816197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eight years of hepatitis B vaccination in Colombia with a recombinant vaccine: factors influencing hepatitis B virus infection and effectiveness.
    de la Hoz F; Perez L; de Neira M; Hall AJ
    Int J Infect Dis; 2008 Mar; 12(2):183-9. PubMed ID: 17913535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term efficacy and persistence of Chinese infants after receiving only active plasma-derived hepatitis B vaccine].
    Xia G; Jia Z; Yan T; Li R; Liu H; Xu Z; Cao H; Liu C
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Jun; 16(2):146-9. PubMed ID: 12196826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Longitudinal Hepatitis B Vaccine Cohort Demonstrates Long-lasting Hepatitis B Virus (HBV) Cellular Immunity Despite Loss of Antibody Against HBV Surface Antigen.
    Simons BC; Spradling PR; Bruden DJ; Zanis C; Case S; Choromanski TL; Apodaca M; Brogdon HD; Dwyer G; Snowball M; Negus S; Bruce MG; Morishima C; Knall C; McMahon BJ
    J Infect Dis; 2016 Jul; 214(2):273-80. PubMed ID: 27056956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune persistence 17 to 20 years after primary vaccination with recombination hepatitis B vaccine (CHO) and the effect of booster dose vaccination.
    Zhao YL; Han BH; Zhang XJ; Pan LL; Zhou HS; Gao Z; Hao ZY; Wu ZW; Ma TL; Wang F; Li Q; Bi SL; Ma JC
    BMC Infect Dis; 2019 May; 19(1):482. PubMed ID: 31146699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influence of three booster doses hepatitis B vaccine on the persistence of immune-protection among infants with normal and high antibody response to primary vaccination: a matched case-control study].
    Feng Y; Lyu J; Liu J; Yan B; Song L; Liang X; Li L; Zhang G; Wang F; Zhang L; Xu A
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Apr; 37(4):460-3. PubMed ID: 27087206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of maternal carrier status on immunologic markers for protection after hepatitis B vaccination in infancy: a meta-analysis.
    Schönberger K; Riedel C; Rückinger S; Mansmann U; Jilg W; von Kries R
    Vaccine; 2012 Sep; 30(44):6314-26. PubMed ID: 22885275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for a change in the epidemiology of hepatitis B virus infection after nearly two decades of universal hepatitis B vaccination in South Africa.
    Amponsah-Dacosta E; Lebelo RL; Rakgole JN; Burnett RJ; Selabe SG; Mphahlele MJ
    J Med Virol; 2014 Jun; 86(6):918-24. PubMed ID: 24615635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of hepatitis B virus infection and carriage after nineteen years of vaccination program in the Western Brazilian Amazon.
    Braga WS; Castilho Mda C; Borges FG; Martinho AC; Rodrigues IS; Azevedo EP; Scazufca M; Menezes PR
    Rev Soc Bras Med Trop; 2012 Feb; 45(1):13-7. PubMed ID: 22370822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lasting immune memory against hepatitis B following challenge 10-11 years after primary vaccination with either three doses of hexavalent DTPa-HBV-IPV/Hib or monovalent hepatitis B vaccine at 3, 5 and 11-12 months of age.
    Avdicova M; Crasta PD; Hardt K; Kovac M
    Vaccine; 2015 May; 33(23):2727-33. PubMed ID: 24962750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.